Takeda Pharmaceutical Company, Ltd

Grantee website osaka-shi, Japan
Purpose
to increase total global capacity to meet potential demand for Inactivated Poliovirus Vaccine (IPV) in 2019/2020, and ensure adequate vaccine supply at an affordable cost.
Division
Global Development
Date
MAY 2016
Region served
GLOBAL
Committed amount
$22,942,125
Grant topic
Polio
Duration (months)
43
Grantee location
osaka-shi, Japan
Program strategy page

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.